Ilaria Plantamura

Amadeo 42 Road
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Correction: Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.

Correction: Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.

Journal: Cell death & disease
Published: March 12, 2025

The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective.

The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective.

Journal: Cancers
Published: September 21, 2022

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.

Journal: Cancer medicine
Published: August 25, 2021

Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay.

Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay.

Journal: Cancers
Published: June 11, 2021

miR-205 in Breast Cancer: State of the Art.

miR-205 in Breast Cancer: State of the Art.

Journal: International journal of molecular sciences
Published: November 09, 2020

miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts.

miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts.

Journal: Cells
Published: July 20, 2020

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer.

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer.

Journal: Cancers
Published: July 09, 2020

MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis.

MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis.

Journal: International journal of molecular sciences
Published: September 27, 2019

MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers.

MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers.

Journal: Frontiers in oncology
Published: February 27, 2018

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.

Journal: Oncotarget
Published: December 30, 2017

Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.

Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.

Journal: Cell death & disease
Published: February 08, 2016

miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.

miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.

Journal: Cancer research
Published: January 21, 2016
Showing 1-12 of 15

Last Updated: 09/26/2026